InvestorsHub Logo
Followers 10
Posts 4220
Boards Moderated 0
Alias Born 07/10/2003

Re: johnnyfiber post# 58273

Wednesday, 02/28/2007 3:34:49 PM

Wednesday, February 28, 2007 3:34:49 PM

Post# of 82595
As of today hundreds of companies are working on personalized medicine. Most are further ahead than DNAG because they haven't been stuck at the starting line for half a decade. Additionally, DNAG built their initial hype on personalized medicine in the form of classifiers such as ovanome and statinome. In the last few months they have changed their tunes and started to refer to those programs to 'research projects'. They have changed course and tied their future to drug development.

As their own PR company will tell anyone who calls them, the next expected revenue generating project is super-EPO and that is not due for years yet.

As of today there is no personalized medicine without DnaPrint . BY ANYBODY. PERIOD. WITH DNAPRINT, PERSONALIZED MEDICINE IS AVAILABLE AND READY TO GO. WHAT DO YOU THINK MERCK WOULD PAY FOR THAT?

As of today Merck has forgotten more about personalized medicine than DNAG will ever know. They wouldn't give an already scratched off lottery ticket for it.

regards,
frog